The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the In...
Strides Pharma Science has announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte. Limited, Si...
ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organizati...
China's BioDlink has announced that its Bevacizumab Injection has obtained marketing authorisation from&n...
Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary o...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
Australia-based contract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and...
Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on t...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...
What were the key drivers behind Syngene’s transition from the Clinical Development department to a more integrate...
Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated the start o...
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC...
